Who makes [124I]meta-Iodobenzylguanidine?

[124I]meta-Iodobenzylguanidine is developed by Cancer Research UK.

What development phase is [124I]meta-Iodobenzylguanidine in?

[124I]meta-Iodobenzylguanidine is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[124I]meta-Iodobenzylguanidine

Cancer Research UK · Phase 1 active Small molecule

At a glance

Generic name	[124I]meta-Iodobenzylguanidine
Sponsor	Cancer Research UK
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[124I]meta-Iodobenzylguanidine CI brief — competitive landscape report
[124I]meta-Iodobenzylguanidine updates RSS · CI watch RSS
Cancer Research UK portfolio CI